J1322 – Injection, elosulfase alfa, 1 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ1322
- Long description
- Injection, elosulfase alfa, 1 mg
- Short description
- Elosulfase alfa, injection
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- January 1, 2015
- Last change
- January 1, 2015 – No change
Frequently asked questions
What is HCPCS code J1322?
J1322 is a HCPCS Level II code for injection, elosulfase alfa, 1 mg.
Does Medicare cover J1322?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J1302 – Injection, sutimlimab-jome, 10 mg
- J1303 – Injection, ravulizumab-cwvz, 10 mg
- J1304 – Injection, tofersen, 1 mg
- J1305 – Injection, evinacumab-dgnb, 5mg
- J1306 – Injection, inclisiran, 1 mg
- J1307 – Injection, crovalimab-akkz, 10 mg
- J1308 – Injection, famotidine, 0.25 mg
- J1320 – Injection, amitriptyline hcl, up to 20 mg
- J1323 – Injection, elranatamab-bcmm, 1 mg
- J1324 – Injection, enfuvirtide, 1 mg
- J1325 – Injection, epoprostenol, 0.5 mg
- J1326 – Injection, zolbetuximab-clzb, 2 mg
- J1327 – Injection, eptifibatide, 5 mg
- J1330 – Injection, ergonovine maleate, up to 0.2 mg
- J1335 – Injection, ertapenem sodium, 500 mg
- J1364 – Injection, erythromycin lactobionate, per 500 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.